Q3 2020 Holdings
Filed 2020-11-12 | 22 holdings | $2.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.3M | 583,232 | 89.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $77.9K | 2,530,494 | 3.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $53.3K | 2,352,291 | 2.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $26.5K | 1,009,117 | 1.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $23.0K | 1,515,148 | 0.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $22.0K | 569,458 | 0.8% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $20.7K | 1,324,364 | 0.8% |
| Akouos Inc | COM | 00973J101 | $19.4K | 846,397 | 0.7% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $12.0K | 2,931,185 | 0.5% |
| American Well Corp | CL A | 03044L105 | $7.4K | 248,352 | 0.3% |
| Precision Biosciences Inc | COM | 74019P108 | $6.3K | 1,014,840 | 0.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $3.5K | 618,092 | 0.1% |
| Kezar Life Sciences Inc | COM | 49372L100 | $1.2K | 246,643 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $970 | 84,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $954 | 7,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $882 | 16,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $721 | 70,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $616 | 7,500 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $603 | 6,500 | 0.0% |
| Livongo Health Inc(LVGO) | COM | 539183103 | $510 | 3,640 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $432 | 8,000 | 0.0% |
| Global Blood Therapeutics inCall | COM | 37890U108 | $26 | 10,000 | 0.0% |